Literature DB >> 19031296

Urinary incontinence and quality of life in long-term gynecological cancer survivors: a population-based cross-sectional study.

Finn Egil Skjeldestad1, Toril Rannestad.   

Abstract

OBJECTIVE: To investigate quality of life (QoL) among women reporting urinary incontinence (UI).
DESIGN: Population-based cross-sectional study.
SETTING: Survival status for all women who had primary treatment between 1987 and 1996 at the University Hospital, Trondheim, Norway, was assessed in 2003. Eligible for study participation were recurrence-free survivors of gynecological cancer and age-matched women selected from the general population.
METHODS: Women who had no history of gynecological cancer were selected as age-matched controls in a 4:1 ratio to survivors in the population census. In 2004, all eligible participants were sent an extensive questionnaire. After one reminder the response rate was 55% (176/319) and 41% (521/1276) for survivors and controls, respectively. UI (total, stress, urge and mixed) was in agreement with definitions of the International Continence Society. QoL was measured by Ferrans and Powers' Quality of Life Index (QLI). The chi-squared test for categorical variables, unpaired T-test for continuous variables and logistic regression were applied.
RESULTS: A history of recurrence-free gynecologic cancer was not associated with reduced QLI. The prevalence of UI was 34.5%. Women with UI had lower scores on total QLI and all domains (health/functioning, psychological/spiritual, socio-economic, and family domain) compared with continent women. A decreasing score of QLI and its domains were found for increasing severity of UI. After adjustment for other co-morbidities UI remained an independent significant predictor of QLI below the 25. percentile, but not for QLI below the 10. percentile.
CONCLUSION: UI has a negative impact on QoL. The more severe UI, the more reduced were total and all QLI domains.

Entities:  

Mesh:

Year:  2009        PMID: 19031296     DOI: 10.1080/00016340802582041

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  5 in total

1.  Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.

Authors:  Helen J Mackay; Lari Wenzel; Linda Mileshkin
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

2.  Bladder and bowel symptoms in cervical and endometrial cancer survivors.

Authors:  Kristine A Donovan; Alice R Boyington; Patricia L Judson; Jean F Wyman
Journal:  Psychooncology       Date:  2014-01-30       Impact factor: 3.894

3.  Survivors of gynecologic malignancies: impact of treatment on health and well-being.

Authors:  Shannon N Westin; Charlotte C Sun; Celestine S Tung; Robin A Lacour; Larissa A Meyer; Diana L Urbauer; Michael M Frumovitz; Karen H Lu; Diane C Bodurka
Journal:  J Cancer Surviv       Date:  2015-08-06       Impact factor: 4.442

4.  Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials.

Authors:  Kathryn Osann; Susie Hsieh; Edward L Nelson; Bradley J Monk; Dana Chase; David Cella; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2014-09-03       Impact factor: 5.482

5.  Climacteric symptoms in postoperative patients among endometrial cancer, cervical cancer, and ovarian cancer: a cross-sectional study.

Authors:  Yuko Horiba; Tetsuhiro Yoshino; Megumi Yokota; Takashi Iwata; Kenji Watanabe; Masaru Mimura; Daisuke Aoki
Journal:  Support Care Cancer       Date:  2022-05-08       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.